Place · Level 3
Exercise as medicine
肌肉是内分泌器官 · 一次收缩同时调代谢、大脑、炎症 — 这是它能改善 10+ 个慢病终点的分子根源
Story path
Chapter 1
Mechanisms — muscle as an endocrine organ
Mechanisms — muscle as an endocrine organ
The 'Fit' in Fitnuhealth lands on this island: exercise is the #1 health lever after nutrition, and in many situations more important than nutrition. The reason it improves so many seemingly unrelated endpoints at once — cardiovascular, glucose metabolism, mood, cognition, musculoskeletal — has a single molecular root: contracting muscle isn't just an engine, it's an endocrine organ.
The main lines (Hawley 2014 review):
Myokines: contracting muscle releases signaling molecules into the blood, including interleukin-6: A pro-inflammatory signal molecule (cytokine) released by immune cells during inflammation. (anti-inflammatory in the exercise context), irisin (inducing BDNF and fat browning), and BAIBA. They cross the blood-brain barrier or act in border regions of the brain — the material basis for exercise improving mood and cognitionGlucose uptake that bypasses insulin: muscle contraction shifts the AMP/adenosine triphosphate: The cell's universal energy currency — almost everything that costs energy spends it. ratio, activates AMP-activated protein kinase: The cell's 'low fuel' sensor — switches on when energy is low to make energy and pause building., and recruits GLUT4 glucose transporters straight to the cell membrane, with no insulin signaling needed at all. This is why exercise still lowers blood glucose in insulin-resistant people, and the training effect lasts 24-48 hoursBDNF upregulation: brain-derived neurotrophic factor supports neural plasticity and hippocampal neurogenesis — the shared pathway behind exercise's effects on depression, cognition, and dementiaAnti-inflammatory: long-term exercise downregulates chronic low-grade inflammation (inflammaging), lowering baseline IL-6 and tumor necrosis factor alpha: A strong pro-inflammatory signal molecule that runs high in chronic inflammation. — which doesn't contradict the transient IL-6 rise during acute exercise, that being a hormesis signalMitochondrial biogenesis: endurance stimulus upregulates the PGC-1α pathway, increasing mitochondrial density and fat oxidation capacity, the cellular basis for improved aerobic capacity
This is why exercise isn't merely 'working out' — it's the broadest, cheapest, and strongest medical intervention. The islands below are its prescriptions for specific diseases.
The main lines (Hawley 2014 review):
Myokines: contracting muscle releases signaling molecules into the blood, including interleukin-6: A pro-inflammatory signal molecule (cytokine) released by immune cells during inflammation. (anti-inflammatory in the exercise context), irisin (inducing BDNF and fat browning), and BAIBA. They cross the blood-brain barrier or act in border regions of the brain — the material basis for exercise improving mood and cognitionGlucose uptake that bypasses insulin: muscle contraction shifts the AMP/adenosine triphosphate: The cell's universal energy currency — almost everything that costs energy spends it. ratio, activates AMP-activated protein kinase: The cell's 'low fuel' sensor — switches on when energy is low to make energy and pause building., and recruits GLUT4 glucose transporters straight to the cell membrane, with no insulin signaling needed at all. This is why exercise still lowers blood glucose in insulin-resistant people, and the training effect lasts 24-48 hoursBDNF upregulation: brain-derived neurotrophic factor supports neural plasticity and hippocampal neurogenesis — the shared pathway behind exercise's effects on depression, cognition, and dementiaAnti-inflammatory: long-term exercise downregulates chronic low-grade inflammation (inflammaging), lowering baseline IL-6 and tumor necrosis factor alpha: A strong pro-inflammatory signal molecule that runs high in chronic inflammation. — which doesn't contradict the transient IL-6 rise during acute exercise, that being a hormesis signalMitochondrial biogenesis: endurance stimulus upregulates the PGC-1α pathway, increasing mitochondrial density and fat oxidation capacity, the cellular basis for improved aerobic capacity
This is why exercise isn't merely 'working out' — it's the broadest, cheapest, and strongest medical intervention. The islands below are its prescriptions for specific diseases.
Dose — the all-cause mortality curve
The all-cause mortality dose-response for exercise is clear (Lee 2012 Lancet plus Wen 2011 Lancet): going from fully sedentary up to moderate exercise (150 min/week) lowers all-cause mortality 30-35%; adding more (300 min/week) gains another 5-10%; very high volumes (over 600 min/week) plateau, no longer linear. Extreme volumes (marathon, triathlon) show some mildly negative signals in studies (arrhythmias, atrial fibrillation), but the risk is far less than being sedentary.A few frequently misread claims, addressed in passing:
'10,000 steps a day': the number comes from 1960s Japanese pedometer marketing, not science. The real evidence is that 4,000-7,000 steps/day already lowers mortality significantly (Paluch 2022 meta)'Just walking is enough': wrong — without strength training, muscle keeps wasting away after 50'Yoga alone is enough': covers flexibility and balance, but cardio and strength are insufficient'HIIT is the most efficient': effective for those with an aerobic base, while complete beginners need to build the base first
If you could pick one intervention to stick to for 30 years, it's not a supplement, nor any 'anti-inflammatory diet' — it's 150 minutes of moderate aerobic per week plus 2-3 resistance training sessions.
Chapter 2
Depression
Depression
The evidence for exercise on depression is strong enough to make it a first-line intervention, not an 'adjunctive measure'. The Cooney 2013 Cochrane review pooled 39 RCTs and 2,326 people, with an effect size of Cohen's d = -0.62 (moderate-to-large) — the same range as the -0.5 to -0.7 typically reported for SSRI antidepressants. Schuch 2016 meta (33 RCTs) revisited it and reached the same conclusion; after correcting for publication bias the effect shrank slightly but remained significant.
So in mild-to-moderate depression, exercise can stand alongside medication and psychotherapy as first-line; severe depression still needs the medication + therapy + exercise combination.
It works through stacking pathways: myokines (interleukin-6: A pro-inflammatory signal molecule (cytokine) released by immune cells during inflammation. anti-inflammatory, irisin inducing BDNF); BDNF upregulation supporting hippocampal neurogenesis; Default Mode Network (DMN) reorganization, where depressive 'rumination' correlates with DMN overactivation and exercise adjusts its activity pattern; hypothalamic–pituitary–adrenal axis: The body's stress-response chain (hypothalamus → pituitary → adrenal) that releases cortisol. axis normalization, with long-term exercise lowering baseline cortisol; plus the genuinely real post-exercise endorphins and endocannabinoids (the 'runner's high').
Prescription (based on Cooney 2013 plus ACSM 2018): moderate intensity (50-70% max HR, can hold a conversation but a bit short of breath — high-intensity HIIT may acutely worsen anxiety, so not first choice), 3-5 times per week, 30-60 minutes each, 150+ minutes total. Walking, running, cycling, and strength training all work (a resistance-training-only meta shows equivalent effect). Peak effect typically arrives at 8 weeks; the first 2-3 weeks may feel like 'this isn't doing anything', which is normal — don't stop.
So in mild-to-moderate depression, exercise can stand alongside medication and psychotherapy as first-line; severe depression still needs the medication + therapy + exercise combination.
It works through stacking pathways: myokines (interleukin-6: A pro-inflammatory signal molecule (cytokine) released by immune cells during inflammation. anti-inflammatory, irisin inducing BDNF); BDNF upregulation supporting hippocampal neurogenesis; Default Mode Network (DMN) reorganization, where depressive 'rumination' correlates with DMN overactivation and exercise adjusts its activity pattern; hypothalamic–pituitary–adrenal axis: The body's stress-response chain (hypothalamus → pituitary → adrenal) that releases cortisol. axis normalization, with long-term exercise lowering baseline cortisol; plus the genuinely real post-exercise endorphins and endocannabinoids (the 'runner's high').
Prescription (based on Cooney 2013 plus ACSM 2018): moderate intensity (50-70% max HR, can hold a conversation but a bit short of breath — high-intensity HIIT may acutely worsen anxiety, so not first choice), 3-5 times per week, 30-60 minutes each, 150+ minutes total. Walking, running, cycling, and strength training all work (a resistance-training-only meta shows equivalent effect). Peak effect typically arrives at 8 weeks; the first 2-3 weeks may feel like 'this isn't doing anything', which is normal — don't stop.
Chapter 3
Type 2 diabetes
Type 2 diabetes
The core problem in T2D is that muscle's insulin response is blunted, so blood glucose can't enter muscle and stays in the blood. The magic of exercise: muscle contraction recruits GLUT4 glucose transporters to the cell membrane via a pathway that doesn't require insulin, pulling glucose in directly. Richter 2013 (Physiol Rev) lays out the mechanism — contraction shifts the AMP/adenosine triphosphate: The cell's universal energy currency — almost everything that costs energy spends it. ratio, activates AMP-activated protein kinase: The cell's 'low fuel' sensor — switches on when energy is low to make energy and pause building., and triggers GLUT4 translocation, bypassing insulin signaling entirely, with the training effect lasting 24-48 hours.
The clinical data carry weight: the DPP trial (2002 NEJM) showed that in high-risk people, diet plus 150 min/week of exercise cut progression to T2D by 58% — more effective than metformin alone (-31%); the Look AHEAD trial showed strength plus aerobic plus weight loss significantly improving HbA1c, with some patients reversing to non-diabetic status; Reynolds 2016 (Diabetologia) showed that 15 minutes of walking immediately after a meal lowered the postprandial glucose peak by about 30% (vs sitting after a meal).
Prescription (Colberg 2016, ADA official consensus): aerobic 150 min/week moderate or 75 min/week vigorous, no more than 2 consecutive rest days; resistance training 2-3×/week; interrupt sitting by standing and moving 3+ minutes every 30 minutes (especially post-meal). Post-meal walking is the most practical single intervention — 15-minute walks after each of three meals control glucose better than one 45-minute walk, and suit working people who can't carve out a long block.
Note for glucose-lowering medication users: insulin or sulfonylurea users have elevated hypoglycemia risk during and 6-12 hours after training — test glucose pre-training, eat carbs first if below 5 mmol/L, carry glucose tabs during; metformin is training-safe; reducing or stopping medication should be physician-guided, not self-decided.
The clinical data carry weight: the DPP trial (2002 NEJM) showed that in high-risk people, diet plus 150 min/week of exercise cut progression to T2D by 58% — more effective than metformin alone (-31%); the Look AHEAD trial showed strength plus aerobic plus weight loss significantly improving HbA1c, with some patients reversing to non-diabetic status; Reynolds 2016 (Diabetologia) showed that 15 minutes of walking immediately after a meal lowered the postprandial glucose peak by about 30% (vs sitting after a meal).
Prescription (Colberg 2016, ADA official consensus): aerobic 150 min/week moderate or 75 min/week vigorous, no more than 2 consecutive rest days; resistance training 2-3×/week; interrupt sitting by standing and moving 3+ minutes every 30 minutes (especially post-meal). Post-meal walking is the most practical single intervention — 15-minute walks after each of three meals control glucose better than one 45-minute walk, and suit working people who can't carve out a long block.
Note for glucose-lowering medication users: insulin or sulfonylurea users have elevated hypoglycemia risk during and 6-12 hours after training — test glucose pre-training, eat carbs first if below 5 mmol/L, carry glucose tabs during; metformin is training-safe; reducing or stopping medication should be physician-guided, not self-decided.
Chapter 4
Hypertension
Hypertension
Three exercise types have different blood-pressure effects (Cornelissen 2013, J Am Heart Assoc meta, 93 RCTs, n=5,223):
Aerobic training (3-5×/week, 30-60 min each, 12+ weeks): SBP down 5-8 mmHg, DBP down 3-5 mmHg, with larger effects in hypertensive patientsStrength training (2-3×/week): SBP down 4 mmHg, DBP down 3 mmHg. The early worry that 'weight training raises BP' has been overturned — there's an acute spike during the lift, but the chronic effect is reductionFlexibility training: no significant effect, not recommended as a standalone BP intervention
The most surprising is isometric exercise (Smart 2019, J Hypertens meta): isometric handgrip training (2 min × 4 sets × 3×/week × 8 weeks) lowers SBP 10.4 mmHg and vitamin D-binding protein: The blood transport protein that carries vitamin D to organs. 6.5 mmHg — an effect size that even exceeds the average single-drug effect of an ACE inhibitor or diuretic (~-8 mmHg). Wall-sit isometrics have a similar effect. The mechanism is reduced peripheral resistance, improved endothelial function, and increased nitric-oxide release. Isometric exercise takes under 8 minutes per session, with equipment as simple as a grip device or a wall — adherence is very high, and it suits older adults and those with joint issues especially well.
There's also an acute after-effect: after one moderate-intensity aerobic session, BP stays 5-7 mmHg lower for 22 hours (Pescatello 2004). Cautions: uncontrolled severe hypertension (≥180/110) should see a doctor first; in strength training, exhale on exertion and don't hold your breath (the Valsalva maneuver acutely raises BP markedly); β-blocker users should set intensity by RPE rather than heart rate; don't stop medication on your own.
Aerobic training (3-5×/week, 30-60 min each, 12+ weeks): SBP down 5-8 mmHg, DBP down 3-5 mmHg, with larger effects in hypertensive patientsStrength training (2-3×/week): SBP down 4 mmHg, DBP down 3 mmHg. The early worry that 'weight training raises BP' has been overturned — there's an acute spike during the lift, but the chronic effect is reductionFlexibility training: no significant effect, not recommended as a standalone BP intervention
The most surprising is isometric exercise (Smart 2019, J Hypertens meta): isometric handgrip training (2 min × 4 sets × 3×/week × 8 weeks) lowers SBP 10.4 mmHg and vitamin D-binding protein: The blood transport protein that carries vitamin D to organs. 6.5 mmHg — an effect size that even exceeds the average single-drug effect of an ACE inhibitor or diuretic (~-8 mmHg). Wall-sit isometrics have a similar effect. The mechanism is reduced peripheral resistance, improved endothelial function, and increased nitric-oxide release. Isometric exercise takes under 8 minutes per session, with equipment as simple as a grip device or a wall — adherence is very high, and it suits older adults and those with joint issues especially well.
There's also an acute after-effect: after one moderate-intensity aerobic session, BP stays 5-7 mmHg lower for 22 hours (Pescatello 2004). Cautions: uncontrolled severe hypertension (≥180/110) should see a doctor first; in strength training, exhale on exertion and don't hold your breath (the Valsalva maneuver acutely raises BP markedly); β-blocker users should set intensity by RPE rather than heart rate; don't stop medication on your own.
Chapter 5
Insomnia
Insomnia
Exercise's effect on insomnia is strong and stable enough to serve as a first-line intervention, not a 'let's try and see' option. Kredlow 2015 (J Behav Med) meta (66 RCTs, acute plus chronic vs control) shows that 4-12 weeks of sustained exercise lowers sleep-onset latency 13 minutes (from 30 to 17), increases total sleep time 19 minutes, improves subjective sleep quality (PSQI) by 0.31 SD (moderate effect), raises the N3 deep-sleep proportion, and improves next-day alertness and mood.
This effect size is similar to cognitive behavioral therapy (CBT-I, the first-line non-drug treatment for insomnia), better than melatonin alone, and comparable to zolpidem-class hypnotics but without the drug side effects. Banno 2018 (PeerJ) meta (9 RCTs in diagnosed insomnia patients) showed PSQI dropping 4.3 after 4-8 weeks of exercise (from 12.5 to 8.2 — clinically significant).
Timing determines how well it works:
Morning training (6-9 AM) is best: bright light, temperature rhythm, and endorphins act together to consolidate the circadian rhythm and advance sleep onset by about 1.5-2 hours — insomniacs should try this slot firstAfternoon (3-7 PM) is second best: peak strength and performance, neutral for sleep, the most practical slot on workdaysEvening 7-9 PM: moderate intensity (walking, jogging, yoga) doesn't hurt sleep, but HIIT plus heavy lifting delays sleep 1-2 hours because core temperature, cortisol, and adrenaline need 2-3 hours to come downLate 9-11 PM: avoid high intensity — even if you can fall asleep, deep-sleep quality clearly drops
Practical for insomniacs: first choice is moderate-intensity morning training 30+ minutes for 4-8 weeks (the first two weeks may feel useless, don't quit early); if evening is your only option, keep it moderate, finish 3+ hours before bed, and take a warm shower afterward (the temperature-rise-then-fall signal aids sleep).
This effect size is similar to cognitive behavioral therapy (CBT-I, the first-line non-drug treatment for insomnia), better than melatonin alone, and comparable to zolpidem-class hypnotics but without the drug side effects. Banno 2018 (PeerJ) meta (9 RCTs in diagnosed insomnia patients) showed PSQI dropping 4.3 after 4-8 weeks of exercise (from 12.5 to 8.2 — clinically significant).
Timing determines how well it works:
Morning training (6-9 AM) is best: bright light, temperature rhythm, and endorphins act together to consolidate the circadian rhythm and advance sleep onset by about 1.5-2 hours — insomniacs should try this slot firstAfternoon (3-7 PM) is second best: peak strength and performance, neutral for sleep, the most practical slot on workdaysEvening 7-9 PM: moderate intensity (walking, jogging, yoga) doesn't hurt sleep, but HIIT plus heavy lifting delays sleep 1-2 hours because core temperature, cortisol, and adrenaline need 2-3 hours to come downLate 9-11 PM: avoid high intensity — even if you can fall asleep, deep-sleep quality clearly drops
Practical for insomniacs: first choice is moderate-intensity morning training 30+ minutes for 4-8 weeks (the first two weeks may feel useless, don't quit early); if evening is your only option, keep it moderate, finish 3+ hours before bed, and take a warm shower afterward (the temperature-rise-then-fall signal aids sleep).
Chapter 6
Sarcopenia
Sarcopenia
EWGSOP2 (Cruz-Jentoft 2019, Lancet) redefined sarcopenia as 'progressive systemic skeletal muscle mass loss accompanied by strength or performance decline' — age-related but NOT inevitable. Diagnosis centers on strength (handgrip below 27 kg for men, 16 kg for women, or 5× sit-to-stand over 15 seconds), graded by low muscle mass and poor performance. Prevalence is 5-13% over age 70, 11-50% over 80; clinical consequences are roughly a 3× rise in falls, 2-4× in hip fracture, and 2-3× in mortality.
Core mechanisms: anabolic resistance (elderly muscle's protein-synthesis response is blunted; the same leucine stimulus produces only 60-70% of the young response); motor units are lost at ~1%/year from age 30, with type-II fast-twitch fibers lost faster; IGF-1, testosterone, and growth hormone decline with age; chronic low-grade inflammation accelerates breakdown.
As of now no drug is approved specifically for sarcopenia; the only strong-evidence intervention is resistance training plus protein:
Progressive resistance training (mandatory): 2-3×/week, 60-80% 1RM moderate-to-high intensity (not 'gentle elderly training'), 8-12 reps × 2-3 sets, compounds first, with 12+ weeks before significant muscle-mass improvement is visibleProtein: total 1.0-1.2 g/kg/day (the elderly RDA of 0.8 g/kg is insufficient), 25-30 g high-quality protein per meal (leucine threshold 2.5-3 g), with concentrating it into one or two meals much less effective; animal protein has better bioavailability than plantVitamin D plus calcium: D at 800+ IU/day, with Bischoff-Ferrari 2019 showing D plus resistance training doubles the strength gain of resistance training alone
A few marketing traps: HMB adds little on top of resistance training plus protein; 'elderly-specific protein powder' is marketing, ordinary whey works the same; a 'senior creatine version' isn't needed, regular creatine works. 'Too old to train' is wrong — Fiatarone 1994 proved significant hypertrophy even at 90.
Core mechanisms: anabolic resistance (elderly muscle's protein-synthesis response is blunted; the same leucine stimulus produces only 60-70% of the young response); motor units are lost at ~1%/year from age 30, with type-II fast-twitch fibers lost faster; IGF-1, testosterone, and growth hormone decline with age; chronic low-grade inflammation accelerates breakdown.
As of now no drug is approved specifically for sarcopenia; the only strong-evidence intervention is resistance training plus protein:
Progressive resistance training (mandatory): 2-3×/week, 60-80% 1RM moderate-to-high intensity (not 'gentle elderly training'), 8-12 reps × 2-3 sets, compounds first, with 12+ weeks before significant muscle-mass improvement is visibleProtein: total 1.0-1.2 g/kg/day (the elderly RDA of 0.8 g/kg is insufficient), 25-30 g high-quality protein per meal (leucine threshold 2.5-3 g), with concentrating it into one or two meals much less effective; animal protein has better bioavailability than plantVitamin D plus calcium: D at 800+ IU/day, with Bischoff-Ferrari 2019 showing D plus resistance training doubles the strength gain of resistance training alone
A few marketing traps: HMB adds little on top of resistance training plus protein; 'elderly-specific protein powder' is marketing, ordinary whey works the same; a 'senior creatine version' isn't needed, regular creatine works. 'Too old to train' is wrong — Fiatarone 1994 proved significant hypertrophy even at 90.
Chapter 7
Cancer survivorship
Cancer survivorship
The Campbell 2019 ACSM Roundtable (a 17-country expert consensus covering 8 common cancer types) is the primary source for current 'cancer plus exercise' guidance, and its core position is a reversal: the standard 1990s advice was 'cancer patients should rest to conserve energy', while ACSM 2019 plus the 2024 update completely overturned this, writing instead 'avoid inactivity; sustain training where possible and progress recovery gradually'.
Unified prescription: aerobic 150 min/week moderate or 75 min/week vigorous; resistance training 2-3×/week, 8-12 reps, moderate loads; flexibility at least 2×/week; balance training is required for older adults or chemo-induced peripheral neuropathy (CIPN) patients.
Supporting clinical outcomes (Mishra 2012 Cochrane meta, n=3,694): cancer-related fatigue SMD -0.85 (a large effect, the strongest fatigue-intervention evidence at the time); quality of life SMD +0.40; depression and anxiety -0.30 each; breast and colon cancer survivors meeting exercise guidelines have 28-44% lower mortality (Schmid 2014 meta); training groups maintain chemotherapy dose intensity better with fewer interruptions. The mechanisms are immune upregulation (NK cell activity up), insulin/IGF-1 pathway modulation, lower chronic inflammation, improved gut microbiota, and increased cardiovascular reserve.
Schmitz 2009 (NEJM) is the most influential RCT in this field — it overturned the 30-year prohibition on resistance training for breast cancer survivors: 141 breast-cancer-related lymphedema survivors did progressive resistance training, and lymphedema not only didn't worsen but symptom severity actually dropped ~50%, retiring the old post-op '5 lb weight limit on that arm' rule.
Red lines (stop training and seek medical care immediately if these appear): new symptoms (chest pain, severe headache, sudden swelling) — stop training immediately and seek care; platelets below 50 × 10⁹/L — avoid impact or high-intensity resistance training; core temperature reaching 38.5°C — don't train; bone-metastasis patients — avoid impact activities and require physician guidance. The physician's default is now 'train', not 'don't train', but still confirm safety with your doctor before starting.
Unified prescription: aerobic 150 min/week moderate or 75 min/week vigorous; resistance training 2-3×/week, 8-12 reps, moderate loads; flexibility at least 2×/week; balance training is required for older adults or chemo-induced peripheral neuropathy (CIPN) patients.
Supporting clinical outcomes (Mishra 2012 Cochrane meta, n=3,694): cancer-related fatigue SMD -0.85 (a large effect, the strongest fatigue-intervention evidence at the time); quality of life SMD +0.40; depression and anxiety -0.30 each; breast and colon cancer survivors meeting exercise guidelines have 28-44% lower mortality (Schmid 2014 meta); training groups maintain chemotherapy dose intensity better with fewer interruptions. The mechanisms are immune upregulation (NK cell activity up), insulin/IGF-1 pathway modulation, lower chronic inflammation, improved gut microbiota, and increased cardiovascular reserve.
Schmitz 2009 (NEJM) is the most influential RCT in this field — it overturned the 30-year prohibition on resistance training for breast cancer survivors: 141 breast-cancer-related lymphedema survivors did progressive resistance training, and lymphedema not only didn't worsen but symptom severity actually dropped ~50%, retiring the old post-op '5 lb weight limit on that arm' rule.
Red lines (stop training and seek medical care immediately if these appear): new symptoms (chest pain, severe headache, sudden swelling) — stop training immediately and seek care; platelets below 50 × 10⁹/L — avoid impact or high-intensity resistance training; core temperature reaching 38.5°C — don't train; bone-metastasis patients — avoid impact activities and require physician guidance. The physician's default is now 'train', not 'don't train', but still confirm safety with your doctor before starting.